Meeting
2016 ASCO Annual Meeting
Impact of a pre-operative exercise intervention on Ki-67 and metabolic markers in women with early breast cancer.
Authors
Jennifer A. Ligibel
Dana-Farber Cancer Institute, Boston, MA
Jennifer A. Ligibel , Anita Giobbie-Hurder , Laura Shockro , Esther Rhei , Susan Troyan , Laura Stewart Dominici , Anees B. Chagpar , Elizabeth S. Frank , Anne McTiernan , Rachel Lynn Yung , Rachel A. Freedman , Sara M. Tolaney , Keelin O'Connor , Kelly Stecker , Deborah Dillon , Melinda L Irwin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Clinical Trial Registration Number
NCT01516190
Citation
J Clin Oncol 34, 2016 (suppl; abstr 564)
DOI
10.1200/JCO.2016.34.15_suppl.564
Abstract #
564
Poster Bd #
52
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
High-dose omega-3 fatty acid supplementation to modulate breast tissue biomarkers in premenopausal women at high risk for development of breast cancer.
First Author: Carol J. Fabian
Poster
2023 ASCO Annual Meeting
Biologic profile to predict overall survival in non-metastatic breast cancer: A latent class analysis on aging biomarkers.
First Author: Claire Falandry
Poster
2022 ASCO Annual Meeting
Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer: ADAPTcycle.
First Author: Nadia Harbeck
Poster
2018 ASCO Annual Meeting
Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812).
First Author: Katherine D Crew